Yazar "Malkan, Umit Y." için listeleme
-
Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan, Umit Y.; Aksu, Salih; Aktimur, Sude H.; Atay, Hilmi; Bektas, Ozlen; Buyukasik, Yahya; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2015)Unsustainable drug prices in chronic myeloid leukemia (CML) and cancer may be causing harm to patients. The aim of this multi-center study is to assess the efficacy of generic imatinib mesylate (IM) over Glivec in terms ... -
The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases
Aktimur, Sude H.; Malkan, Umit Y.; Eyupoglu, Damla N.; Haznedaroglu, Ibrahim C.; Kelkitli, Engin; Atay, Hilmi M.; Turgut, Mehmet (Akad Doktorlar Yayinevi, 2016)Ruxolitinib as a JAK1 and JAK2 inhibitor drug has recently been approved for the treatment of patients with high-or intermediate-risk myelofibrosis with symptomatic splenomegaly. Clinical development of ruxolitinib has ...
